Author： Schöttle Daniel Kuhnigk Olaf Naber Dieter
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.12, Iss.6, 2013-11, pp. : 897-903
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A review of olanzapine pamoate
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 11, 2012-08 ,pp. :
Access to resources
Recommend
Olanzapine pamoate for the treatment of schizophrenia
By Naber Dieter
Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 4, 2011-03 ,pp. :
Drug safety evaluation of defibrotide
Expert Opinion on Drug Safety, Vol. 12, Iss. 1, 2013-01 ,pp. :
Drug safety evaluation of amlodipine
By Derosa Giuseppe Maffioli Pamela
Expert Opinion on Drug Safety, Vol. 10, Iss. 5, 2011-09 ,pp. :
Drug safety evaluation of exemestane
By Lintermans Anneleen Neven Patrick Paridaens Robert
Expert Opinion on Drug Safety, Vol. 10, Iss. 3, 2011-05 ,pp. :